Sahar Saleh Alghamdi

21PUBLICATIONS
41CO-AUTHORS
Nanotoxicology, health and safetyArtificial life and complex adaptive systemsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 27, 2026
Nanoparticle-Enabled Biomaterials for Controlled Drug Delivery in Implantable and Wearable Devices.

|Jun 25, 2026
Artificial Intelligence in Selected Domains of Drug Discovery: A Critical Narrative Review.

|Apr 22, 2026
Assessment of the Correlation Between Hypoalbuminemia and Adverse Effects of Oral Anticancer Medications in Adult Patients with Solid Tumors: A Single-Center Retrospective Cohort Study in Saudi Arabia.

|Oct 28, 2025
Reticuline and Coclaurine Exhibit Vitamin D Receptor-Dependent Anticancer and Pro-Apoptotic Activities in the Colorectal Cancer Cell Line HCT116.

Hind A Alghamdi, Sahar S Alghamdi, Maryam Hassan Al-Zahrani

|May 12, 2025
Boswellia carteri Birdw. Resin Extract Induces Phase-I Cytochrome P-450 Enzyme Gene Expressions in Human Hepatocarcinoma (Hep G2) Cells: In vitro and in silico Studies.

Sahar S Alghamdi, Hussah N Albahlal, Raghad Saleh Alajmi

|Aug 12, 2024
Aspergillus Species from the Sabkha Marsh: Potential Antimicrobial and Anticancer Agents Revealed Through Molecular and Pharmacological Analysis.

Bayan H Sajer, Wafa A Alshehri, Sahar S Alghamdi

Pageof 4

Frequent Collaborators

13 joint publications

Rasha Suliman

5 joint publications

Rizwan Ali

5 joint publications

Sabine Matou-Nasri

4 joint publications

Zeyad I Alehaideb